GLAXOSMITHKLINE PHARMA A/S: Financial statements 2014
CVR: 27394019
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 371,489,000 and a net result of DKK 11,764,000 compared with DKK 14,472,000 the year before. That is an increase of 2% compared with the year before. The profit margin was 3.2%. Equity in the 2014 report amounted to DKK 144,270,000. The solvency ratio was 62.8%. The company had 92 employees in the financial year.
- Revenue
- DKK 371,489,000
- Gross Profit
- DKK 119,233,000
- Profit/Loss
- DKK 11,764,000
- Equity
- DKK 144,270,000
- Total Assets
- DKK 229,869,000
- Employees
- 92
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 371.5 mio. | 119.2 mio. | 11.8 mio. | 144.3 mio. | 92 |
| 2013 | 364.3 mio. | 127 mio. | 14.5 mio. | 146.9 mio. | 109 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2013. Revenue came to DKK 364,257,000, and the net result was DKK 14,472,000.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.